News

King's College London, a public research university, is using messenger RNA (mRNA) technology to battle the physiological effects of cardiac arrest in the hopes of developing the world's first heart attack treatment. The technology has the ability to reverse...

To become self-reliant, Union Commerce and Industry Minister of India, Piyush Goyal advised the domestic pharmaceutical sector to develop its generic medicine segment and provide greater synergy between input and output of products. Goyal, speaking at an event organised by the...

Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario. The company’s CEO, Bobby Sheng, said the expansion,...

On April 16th, Shanghai reported a new high for symptomatic COVID-19 cases, while other cities throughout China tightened controls as the country continued its "dynamic clearing" strategy to eradicate the highly communicable Omicron form. A day before, the Zhengzhou Airport...

The fresh, new, astonishingly efficient COVID-19 vaccines were rolling out across the US this time last year, injecting a strong note of confidence into the country's formerly stumbling pandemic response. Hundreds of thousands of people were queuing up every day to get...

The phase 2/3 clinical trials for Bharat Biotech's COVID-19 vaccine, Covaxin, in the United States have been halted by the US Food and Drug Administration. As per a press release from Ocugen Inc., Bharat Biotech's partner for Covaxin in...

Over the past six weeks, leading aircraft specialist, Air Charter Service, has arranged more than 65 charter flights carrying 3,000 tonnes from China to Australia. Each flight had more than one million Covid test kits on board. The test kits...